Lexicon Pharmaceuticals, Inc. (LXRX)

Healthcare · Biotechnology · NASDAQ

Lexicon Pharmaceuticals, Inc. (LXRX) is a Healthcare company in the Biotechnology industry. It has a market capitalization of $1.10B and a free-cash-flow yield of -7.6%. Over the most recent reported fiscal year, revenue grew 60.2%.

Market cap	$1.10B
Trailing P/E	—
FCF yield	-7.6%
Revenue growth (YoY)	+60.2%
EPS growth (YoY)	—
FCF/share growth (YoY)	—
Exchange	NASDAQ
Sector	Healthcare
Industry	Biotechnology

Explore live LXRX data on Nama Insights →